IPIRA Startups

IPIRA Startups

Avista Therapeutics

Brief Description

Avista Therapeutics develops innovative gene therapies for retinal diseases, including rare ophthalmic conditions that have a profound impact on quality of life. The company leverage a computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors. A quantitative, in vivo-based approach and clinical ophthalmology expertise allows Avista Therapeutics to rapidly translate new gene therapies to the clinic.

Inventors

Stephen Graf Brohawn, Hillel Adesnik, Madeline McCloud

Company Founders

Leah Byrne (UC Berkeley PhD, 2007...

AsparaGlue

Brief Description

AsparaGlue has developed a superglue-like medical adhesive for external wound closure and internal tissue adhesion. The proprietary technology is the world’s only biocompatible and biodegradable medical superglue.

Timeline 2023. Company founded; joins Berkeley Skydeck accelerator, cohort 16 Inventors

Philip Messersmith, Subhajit Pal, Ji Soo Shin, Kelsey Gray DeFrates

Ergodicity

Brief Description

Ergodicity develops analytical methods for the age of AI. The company takes a data-first approach to create next-generation optical tools that set new standards in the accessibility of information in chemical and biophysical analytics for biotech.

Inventors

Hendrik Utzat

Company Founders

UC Berkeley Assistant Professor of Chemistry Hendrik Utzat and Richard Maceiczyk

Timeline 2025. Company founded

Azalea Therapeutics, Inc.

Brief Description

Azalea Therapeutics is an early-stage biotech startup on a mission to revolutionize genomic medicines. By designing vehicles that enable cell-specific delivery inside the body, the company aims to unlock precision therapeutics for genetic diseases and unleash the promise of cellular-based therapies.

Inventors

Connor Tsuchida, Jennifer Doudna, Jennifer Hamilton

Company Founders

UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology Jennifer Doudna, Jennifer Hamilton (UC Berkeley PhD, Doudna Lab, 2018-2023); Connor Tsuchida (UC Berkeley...

RareTerra, Inc.

Brief Description

RareTerra is developing a one-step environmentally friendly bio-process for selective rare-earth element (REE) extraction, separation, and purification that doesn't rely on harsh acids or high temperatures and pressures. RareTerra’s technology eliminates the costliest and most hazardous steps of the manufacturing process, and is compatible with complex, dilute, and waste REE sources. The company's proprietary process leverages the power of genetic and metabolic engineering to unlock the remarkable capacity of microbes to separate REEs from other metals and bioaccumulate...

Generation Lab

Brief Description

Generation Lab provides the first and only platform that measures the effectiveness of longevity interventions to identify what works. Co-founded by pre-eminent aging and longevity researcher Dr. Irina Conboy from UC Berkeley, Generation Lab combines an easy-to-use test with proprietary techniques to definitively measure molecular disbalance that indicates aging and risk of disease before symptoms arise. The company works with clinicians who can recommend personalized interventions to increase health, wellness, and longevity; and Generation Lab uniquely measures the...

RoadSafe GIS, Inc.

Brief Description

Our team is bringing modern technology to collision data management. We have seen too many outdated or complex software tools in the field and felt there was a better way. We are dedicated to providing a clean, effective means to manage collision data. We want to empower traffic safety practitioners and help them reduce the number and severity of motor vehicle collisions on our roadways.

We have a strong background in engineering, GIS, cloud technology, programming and research. That is the heart of RoadSafe GIS. We are excited to be providing our service and look...

Axent Biosciences

Brief Description

Axent Biosciences is a pre-clinical stage biotechnology company developing next generation stem cell therapies to address unmet medical needs in human diseases/disorders. The company was spun out of research discoveries in the lab of UC Berkeley Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience David Schaffer. Axent's platform technologies in stem cell manufacturing and implantation leverage 20+ years of stem cell expertise and 10+ years of biomaterials engineering to overcome major bottlenecks in the clinical development...

Valitor Inc.

Brief Description

Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity, and bioactivity. The company's technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. The lead product will be used to improve the treatment of diseases in ophthalmology. The company also has development pipelines for oncology and orthopedics products.

The company was incubated at Berkeley Skydeck, UC Berkeley's...

SirenOpt

Brief Description

SirenOpt provides manufacturing intelligence solutions that accelerate research and development and enable cost-effective manufacturing of high-performance micro- and nano-materials, including lithium-ion batteries, membranes, semiconductors, flexible electronics, packaging materials, and many others. The company's real-time manufacturing intelligence platform, designed for cost-effective manufacturing of thin films, utilizes cold atmospheric plasma and physics-informed machine learning to collect critical manufacturing data and improve manufacturing quality and output....